No discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA

Published On 2020-01-16 06:56 GMT   |   Update On 2022-12-23 05:30 GMT

New Delhi: The Indian Pharmaceutical Alliance (IPA) on Wednesday said Prime Minister Narendra Modi had convened a meeting with the healthcare industry on January 1, but there was "no discussion at all on the alleged bribes being given by pharma companies to doctors."

"There was no discussion at all on the alleged bribes being given by pharma companies to doctors as being reported in the media. The meeting was a constructive one where the discussion was limited to initiatives to boost the industry. News reports to the contrary are baseless," said the IPA in a statement.

The meeting was attended by Satish Reddy (Dr Reddy's), Ajay Piramal (Piramal Group), Pankaj Patel (Cadila Healthcare), Dilip Shanghvi (Sun Pharma), Habil Khorakiwala (Wockhardt), Dr Rajiv Modi (Cadila Pharma), Sudhir Mehta (Torrent), Pavan Choudhary (MedTech) and Shobana Kamineni (Apollo Hospitals), added the IPA.

It added that the meeting was called to "discuss future roadmap for the growth of the healthcare industry."

Research and Development, building innovation ecosystem, improve access to high quality medicine and strengthen global competitiveness of the industry were among the focus of discussion.

"India is rightly described as the pharmacy of the world with 20 per cent volume share of the global market. The purpose was to take the industry to next level and leverage opportunities going forward in pharma sector besides discussing growth opportunities in Medtech and hospital sector," the IPA further said.

Read Also: Follow Ethical Marketing, Do NOT Bribe Doctors: PM Modi Warns Pharma Giants


Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News